1
|
Schwartz IVD, Pinto LLC, Breda G, Lima L, Ribeiro MG, Mota JG, Acosta AX, Correia P, Horovitz DDG, Porciuncula CGG, Lipinski-Figueiredo E, Fett-Conte AC, Oliveira Sobrinho RP, Norato DYJ, Paula AC, Kim CA, Duarte AR, Boy R, Leistner-Segal S, Burin MG, Giugliani R. Clinical and biochemical studies in mucopolysaccharidosis type II carriers. J Inherit Metab Dis 2009; 32:732-738. [PMID: 19821143 DOI: 10.1007/s10545-009-1275-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/24/2008] [Revised: 08/18/2009] [Accepted: 08/25/2009] [Indexed: 12/31/2022]
Abstract
The aim of the study was to characterize clinically and biochemically mucopolysaccharidosis type II (MPS II) heterozygotes. Fifty-two women at risk to be a carrier, with a mean age of 34.1 years (range 16-57 years), were evaluated through pedigree analysis, medical history, physical examination, measurement of iduronate sulfatase (IDS) activities in plasma and in leukocytes, quantification of glycosaminoglycans (GAGs) in urine, and analysis of the IDS gene. Eligibility criteria for the study also included being 16 years of age or older and being enrolled in a genetic counselling programme. The pedigree and DNA analyses allowed the identification of 40/52 carriers and 12/52 non-carriers. All women evaluated were clinically healthy, and their levels of urinary GAGs were within normal limits. Median plasma and leukocyte IDS activities found among carriers were significantly lower than the values found for non-carriers; there was, however, an overlap between carriers' and non-carriers' values. Our data suggests that MPS II carriers show lower plasma and leukocyte IDS activities but that this reduction is generally associated neither with changes in levels of urinary GAGs nor with the occurrence of clinical manifestations.
Collapse
Affiliation(s)
- I V D Schwartz
- Department of Genetics, UFRGS, Porto Alegre, Brazil.
- Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, 90035-903, Porto Alegre, RS, Brazil.
| | - L L C Pinto
- Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, 90035-903, Porto Alegre, RS, Brazil
- Pediatrics Post Graduation Program, School of Medicine, UFRGS, Porto Alegre, Brazil
| | - G Breda
- Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, 90035-903, Porto Alegre, RS, Brazil
| | - L Lima
- Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, 90035-903, Porto Alegre, RS, Brazil
| | - M G Ribeiro
- Clinical Genetics Service, IPPMG, UFRJ, Rio de Janeiro, Brazil
| | - J G Mota
- Institute of Oncology of the South of Minas Gerais (ISMO), Pouso Alegre, Brazil
| | - A X Acosta
- Department of Pediatrics, School of Medicine of Bahia, UFBA, Salvador, Brazil
| | - P Correia
- Post Graduation Program in Women and Children Health, Fernandes Figueira Institute, FIOCRUZ, Rio de Janeiro, Brazil
| | - D D G Horovitz
- Department of Medical Genetics, Fernandes Figueira Institute, FIOCRUZ, Rio de Janeiro, Brazil
| | - C G G Porciuncula
- Clinical Genetics Service, University Hospital, UFAL, Maceió, Brazil
| | | | - A C Fett-Conte
- Department of Molecular Biology, FAMERP, São José do Rio Preto, Brazil
| | | | - D Y J Norato
- Department of Medical Genetics, UNICAMP, Campinas, Brazil
| | - A C Paula
- Genetics Unit, IC-HC-USP, São Paulo, Brazil
| | - C A Kim
- Genetics Unit, IC-HC-USP, São Paulo, Brazil
| | - A R Duarte
- Medical Genetics Service, IMIP, Recife, Brazil
| | - R Boy
- Pediatrics Department, UERJ, Rio de Janeiro, Brazil
| | - S Leistner-Segal
- Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, 90035-903, Porto Alegre, RS, Brazil
| | - M G Burin
- Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, 90035-903, Porto Alegre, RS, Brazil
| | - R Giugliani
- Department of Genetics, UFRGS, Porto Alegre, Brazil
- Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, 90035-903, Porto Alegre, RS, Brazil
- Pediatrics Post Graduation Program, School of Medicine, UFRGS, Porto Alegre, Brazil
| |
Collapse
|
2
|
Vedolin L, Schwartz IVD, Komlos M, Schuch A, Puga AC, Pinto LLC, Pires AP, Giugliani R. Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. AJNR Am J Neuroradiol 2007; 28:1029-33. [PMID: 17569950 PMCID: PMC8134159 DOI: 10.3174/ajnr.a0510] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE There are no reliable markers to predict neurologic outcome of patients with mucopolysaccharidosis (MPS) II. We hypothesized that brain MR imaging and MR spectroscopy are useful in depicting features related to cognitive impairment (CI) in MPS II. MATERIALS AND METHODS Nineteen male patients with MPS II were included in this study. They were evaluated through intelligence/developmental tests to be classified in 2 groups: patients with CI (group A) or patients without CI (group B). Brain MR imaging evaluated white matter (WM) lesions, hydrocephalus, and brain atrophy. Voxels from MR spectroscopy (point-resolved spectroscopy TE 30 ms) were positioned in the WM of the deep right frontal lobe and at the gray matter (GM) in the posterior occipital cortex across the midline. Comparison of MR imaging and MR spectroscopy findings between these 2 groups and a control group was performed. RESULTS The mean age of the patients was 9.6 years (group A, 7.08 years old, 12 patients; group B, 14 years old, 7 patients; P = .076). Brain atrophy and hydrocephalus were more frequently found in group A patients (P=.006 and P=.029, respectively); these patients also presented more severe WM lesions than patients from group B (P=.022). Patients from group A also had a higher myo-inositol (mIns)/creatine (Cr) ratio in the GM (P=.046) and in the WM (P=.032). The choline/Cr and N-acetylaspartate/Cr ratios were similar in both groups. CONCLUSIONS Our study showed that severe WM lesions, brain atrophy, hydrocephalus, and elevated mIns/Cr were more common in patients with MPS II and with CI.
Collapse
Affiliation(s)
- L Vedolin
- Neuroradiology Department, Mãe de Deus Center and Hospital Mãe de Deus, Porto Alegre, Brazil.
| | | | | | | | | | | | | | | |
Collapse
|
3
|
Zen PRG, Pinto LLC, Graziadio C, Pereira VB, Paskulin GA. Association of microcephaly and cafe-au-lait spots in a patient with ring chromosome 12 syndrome. Clin Dysmorphol 2005; 14:141-143. [PMID: 15930904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
We describe a patient who was evaluated because of delayed development. The patient had microcephaly and cafe-au-lait spots and the facial features included upward slanting of the palpebral fissures, short nasal bridge and a highly arched palate. In addition the external ears had bilateral over folded helices, there was clinodactyly of the fourth and fifth fingers and multiple cafe-au-lait spots on the back, buttocks and thighs. Chromosomal analysis of peripheral blood showed 46,XY,-r(12)(p13.3q24.33)[73]/45,XY,-12[8]/47,XY,r(12)(p13.3q24.33),+r(12)(p13.3q24.33)[2]. This is the eighth case of a patient with a ring chromosome 12 to be reported so far. The similarity of our patient to those previously described suggests that the ring chromosome 12 syndrome can be delineated as a distinct entity with characteristic clinical features.
Collapse
Affiliation(s)
- P R G Zen
- Programa de Pós-Graduação em Patologia and Disciplina de Genética Clínica Disciplina de Genética Clinica, Fundação Faculdade Federal de Ciências Médicas, Rua Sarmento Leite 245/403, Porto Alegre, RS 90050-170, Brazil
| | | | | | | | | |
Collapse
|